Song Guo Zheng | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Song Guo Zheng | Drug Discovery and Development | Best Researcher Award

Chair Professor at Shanghai Jiao Tong University School of Medicine | China

Prof. Song Guo Zheng, M.D., Ph.D., is an internationally renowned immunologist and clinician-scientist specializing in rheumatology, molecular immunology, and translational medicine. He currently serves as Chair Professor and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University. With academic leadership roles across prestigious institutions in the U.S. and China, his pioneering work spans autoimmunity, cell therapy, and immunoregulation. A prolific author with over 110 peer-reviewed publications in top-tier journals, Prof. Zheng is also a highly decorated researcher and active leader in global immunology societies. His contributions continue to shape modern immunotherapy and precision medicine.

Publication Profile 

Google Scholar

Orcid

Education 

Prof. Zheng earned his Ph.D. in Molecular Immunology from the University of Orleans, France (2011), and a Master’s in Pathology and Immunology from Shanghai Medical University (1992). He completed his M.D. at Anhui Medical University (1984). His clinical training included a residency in surgery at Chizhou City Hospital (1984–1989) and an internship at Shanghai Zhabei Hospital (1983–1984). He further pursued a pathology fellowship at Shanghai Medical University Cancer Hospital (1989–1993). These academic and clinical foundations laid the groundwork for a distinguished career in immunology, clinical research, and translational medicine across both China and the United States.

Experience 

Prof. Zheng currently serves as Chair Professor at Shanghai Jiao Tong University and Dean of the School of Cell and Gene Therapy (2023–Present). He previously held senior positions including the Ronald L. Whisler Chair in Rheumatology and Immunology at Ohio State University (2018–2022) and Director at Penn State University’s College of Medicine (2013–2018). His U.S. academic journey began at the University of Southern California as an assistant and associate professor (2004–2013), after postdoctoral work at USC and UCLA. With leadership in research, teaching, and clinical science, he has become a global authority in immunological therapeutics and rheumatology.

Awards

Prof. Zheng has received numerous prestigious honors, including the Outstanding Scientist Award (2023, USA) and the Distinguished Clinical Immunologist Award (2019, China). He was awarded the Edmund L. Dubois Award (2019), NIH STAR Award (2016–2021), and was Chair of NIH MOSS Study Section (2016). Notably, he earned the James R. Klinenberg Award for best immunologist in Southern California (2007) and the Freda Newton Memorial Scholar Award (2006). He is an elected member of The Henry Kunkel Society (2012) and a recipient of the ACR Investigator Award (2008–2010), reflecting his impactful and sustained contributions to clinical immunology.

Research Focus 

Prof. Zheng’s research centers on molecular immunology, particularly in autoimmune diseases, Treg/Th17 cell modulation, and immune tolerance mechanisms. He investigates immunometabolism, gene and cell therapy, and inflammatory signaling pathways with an emphasis on clinical translation. His studies on cytokines, nanomedicine, and immune checkpoint regulation aim to advance precision therapeutics for rheumatic and inflammatory diseases. He integrates cutting-edge techniques including single-cell sequencing, CRISPR-based modulation, and nano-drug delivery systems. His innovative research is highly cited and supports next-generation treatments for autoimmunity, cancer immunotherapy, and organ-specific inflammation, shaping global trends in immune-based medical interventions.

Publication Top Notes

Natural and induced CD4+ CD25+ cells educate CD4+ CD25− cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10

IL-2 is essential for TGF-β to convert naive CD4+ CD25− cells to CD25+ Foxp3+ regulatory T cells and for expansion of these cells

Role of vitamin A in the immune system

Generation ex vivo of TGF-β-producing regulatory T cells from CD4+ CD25− precursors

Vitamin D and chronic diseases

TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+ CD25+ regulatory cells

Natural and TGF-β–induced Foxp3+ CD4+ CD25+ regulatory T cells are not mirror images of each other

Role of TNF–TNF receptor 2 signal in regulatory T cells and its therapeutic implications

Cutting edge: Foxp3+ CD4+ CD25+ regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6

Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets

Conclusion

Given his outstanding scientific productivity, leadership in global immunology communities, and groundbreaking research on immune regulation, Prof. Song Guo Zheng is highly suitable for the Best Researcher Award. His body of work demonstrates not only scientific depth and innovation but also sustained impact on the field of immunology and clinical medicine. With ongoing contributions and strategic improvements, he remains a central figure in advancing immune-based therapies and education worldwide.

Moses Owoicho Abah | Bioinformatics in Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Moses Owoicho Abah | Bioinformatics in Pharmaceuticals | Best Researcher Award

Dr. Moses Owoicho Abah at World-Class Research Center “Digital biodesign and personalized healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia, Russia.

Dr. Moses Owoicho Abah is a passionate cancer researcher and molecular oncologist 🧪, currently pursuing a Ph.D. in Oncology/Radiation Therapy 🎓 at I.M. Sechenov First Moscow Medical University. With academic roots in Biochemistry, Bioinformatics, and Medical Biochemistry 🧠, he specializes in RNA sequencing, immunoassays, and biomarker discovery. Dr. Abah has worked across leading institutions in Nigeria and Russia 🇳🇬🇷🇺, contributing to drug discovery, genomics, and personalized oncology. He brings deep expertise in data analysis using Python and R 📊, and his impactful research is published in Scopus-indexed journals 📚. His goal is to revolutionize cancer treatment globally.

Publication Profile 

Google Scholar

Education

Dr. Moses Owoicho Abah’s educational path reflects his unwavering dedication to biomedical sciences and cancer research 🧬. He is currently pursuing a Ph.D. in Oncology/Radiation Therapy (2022–2025) at the Institute for Personalized Oncology, I.M. Sechenov First Moscow Medical University 🇷🇺. He earned his M.Sc in Medical Biochemistry (2020–2022) from the University of Abuja 🇳🇬 and completed a Professional Program in Bioinformatics (2019–2020) at MIPT, Russia. His foundation lies in a B.Sc (Hons) in Biochemistry (2010–2015) from FUAM and a Senior School Certificate from GSS Otukpo (2002–2007) 📚. His journey blends science, research, and innovation.

Experience

Since February 2025, Dr. Moses Owoicho Abah has served as a Cancer Research Coordinator at the Genetics, Genomics, and Bioinformatics Department of the National Institute for Cancer Research and Treatment, Nigeria 🇳🇬. He collaborates closely with the Principal Investigator to uphold global research standards 🌍, prepares proposals, budgets, protocols 📄, and handles informed consent and participant screening ✅. Skilled in RStudio and Python 📊🐍, he generates complex data visuals, manages study supplies, and maintains communication with stakeholders. He also revises and submits manuscripts to top journals 📚, contributing meaningfully to global cancer research.

Awards

Dr. Moses Owoicho Abah has received multiple prestigious awards for his excellence in research and academics 🎓. In July 2021, he was honored with the Associate Fellow Award (CMRf-Bioinformatics) by the Royal Society of Clinical and Academic Researchers of Nigeria (ROSCARON) 🧬. In February 2020, he emerged Overall Best Scholar in Clinical Medicine, Chemistry & Biology during the Russian Open Door Scholarship competition 🇷🇺. Earlier, in August 2018, he was conferred an Honorary Fellow Award by the Association of Economists and Statisticians of Nigeria (AESN) 📈—a testament to his cross-disciplinary brilliance.

Research Focus 

Dr. Moses Owoicho Abah’s research lies at the intersection of oncology, molecular medicine, and bioinformatics 🧪. His work focuses on cancer biology, particularly angiogenesis, cytokine signaling, and drug resistance mechanisms in lung and renal cancers 💉🩸. He explores innovative therapies targeting biomarkers using comparative transcriptomics and RNA sequencing for precision medicine. Additionally, he investigates the toxicological effects of everyday compounds, such as triclosan 🧼, and their impact on hormonal balance. His studies also include natural product pharmacology and the anti-diabetic potential of medicinal plants 🌿, bridging traditional medicine with modern therapeutic strategies.

Publication Top Notes

Dr.Alice Bejjan| Pharmaceutical Analysis| Women Researcher Award

Published on by Top Pharmaceutical

Dr.Alice Bejjan,Pharmaceutical Analysis ,Women Researcher Award

Dr.Alice Bejjan, at ational Council for Scientific Research of Lebanon-Lebanese Atomic Energy Commission, Lebanon

 Profiles

Scopus

Google scholar         

Orcid

🎓Early Academic Pursuits :

Alice Bejjani’s journey into the world of physics began with a solid academic foundation. She pursued her undergraduate studies at the Lebanese University, Department of Physics and Electronics in Fanar, Lebanon, where she earned her Maitrise in Physics with high distinction in 2003. Her passion for materials science and electronic components led her to continue her studies at the Lebanese University, Faculty of Sciences. There, she obtained a Master of Advanced Studies (DEA) in 2004, once again graduating with high distinction. Alice’s academic pursuits culminated in a Ph.D. in Physics from the Claude Bernard University of Lyon, Institute of Nuclear Physics, France, in 2009, where she achieved the highest honors.

🏢Professional Endeavors :

Alice’s professional career is marked by her extensive contributions to the Lebanese Atomic Energy Commission-National Council for Scientific Research (LAEC-NCSR). She began her journey as a part-time research assistant at the Accelerator Laboratory of LAEC-NCSR in 2004-2005. Following her Ph.D., she returned to LAEC-NCSR as a part-time researcher, equivalent to a post-doctoral position, from 2010 to 2014. During this time, she played a pivotal role in establishing the first research laboratory in the MENA region for surface, chemical, and structural analysis of solid materials using the Time of Flight Secondary Ion Mass Spectrometry (TOF-SIMS) technique.

In 2014, Alice was appointed as a full-time researcher at LAEC-NCSR, a position she held until 2019. Her research interests include exploring novel applications, developing innovative protocols, and combining ion beam technology with optical spectroscopic and chromatography methods to examine materials pertinent to health, environmental studies, and forensic sciences. Since 2019, she has been serving as a senior researcher, furthering her contributions to the field.

🔬Contributions and Research Focus :

Alice’s research has had a profound impact on the fields of health, environmental studies, and forensic sciences. As the coordinator of the Forensic Research Program at LAEC-NCSR since 2016, she has fostered synergy among her fellow researchers to achieve program objectives. She has designed and implemented Memorandums of Understanding (MOUs) with partners, driving impactful advancements in forensic research.

As the principal investigator of the TOF-SIMS laboratory, Alice oversees a team of researchers, research assistants, and master’s/Ph.D. students. She has established and enforced standard operating protocols to ensure compliance with safety and regulatory guidelines, maintained the laboratory’s cutting-edge status through equipment procurement and technology advancements, and implemented preventive maintenance plans to ensure optimal functionality and efficiency. Her efforts have also included fostering collaborations with local and international universities and research centers.

 🏆Accolades and Recognition :

Alice’s dedication and contributions to science have been recognized through various national and international grants. Notable among these are:

  1. TC-IAEA Grant (2022-2025): €405,000 for strengthening forensic needs in material investigation.
  2. NCSR National Grant (2018-2019): $19,000 for multi-dimensional analysis of new functional polymers.
  3. NCR Italy-NCSR Mobility Grant (2017-2019): €8,000 for safeguarding saffron authenticity using innovative mass spectrometry.
  4. TC-IAEA Grant (2015-2018): €350,000 for enhancing forensic science capabilities.
  5. TC-IAEA Grant (2012-2014): €350,000 for upgrading surface, elemental, and structural analysis capabilities.
  6. TC-IAEA Grant (2010-2012): €522,000 for enhancing the LAEC’s analytical capabilities.

🌟Impact and Influence :

Alice’s work has had a significant impact on the scientific community and beyond. Her research has contributed to advancements in forensic science, health, and environmental studies. By developing innovative protocols and combining ion beam technology with other analytical methods, she has opened new avenues for material analysis. Her leadership in establishing and maintaining the TOF-SIMS laboratory has provided valuable resources for researchers in the MENA region and internationally.

🌍Legacy and Future Contributions :

Alice Bejjani’s legacy is one of dedication, innovation, and collaboration. Her contributions to the scientific community, particularly in the fields of forensic science and material analysis, have set a high standard for future researchers. As she continues her work at LAEC-NCSR, she is poised to make further advancements in her field, fostering interdisciplinary collaboration and driving impactful research. Her commitment to mentoring the next generation of scientists ensures that her influence will continue to be felt for years to come. Alice’s journey is a testament to the power of perseverance, passion, and the pursuit of excellence in science.

🎓Publication 

Fe0-based trimetallic systems for the removal of aqueous diclofenac: Mechanism and kinetics

  • Authors   :Antoine Ghauch, Hala Abou Assi, Habib Baydoun, Al Muthanna Tuqan, Alice Bejjani
  • Journal    :Chemical Engineering Journal
  • Year         : 2011

Iron-based metal organic framework MIL-88-A for the degradation of naproxen in water through persulfate activation

    • Authors : Rime El Asmar, Abbas Baalbaki, Zahraa Abou Khalil, Sahar Naim, Alice Bejjani, Antoine Ghauch
    • Journal   :Chemical Engineering Journal
    • Year       : 2011
Toward cell selective surfaces: cell adhesion and proliferation on breath figures with antifouling surface chemistry
  • Authors  : Enrique Martínez-Campos, Tamara Elzein, Alice Bejjani, Maria Jesús García-Granda, Ana Santos-Coquillat, Viviana Ramos, Alexandra Muñoz-Bonilla, Juan Rodríguez-Hernández
  • Journal    :ACS Applied Materials & Interfaces
  • Year         :  2016
Hydrophobization of chitosan films by surface grafting with fluorinated polymer brushes
  • Authors  : Bénédicte Lepoittevin, Tamara Elzein, Diana Dragoe, Alice Bejjani, Frédéric Lemée, Jocelyne Levillain, Philippe Bazin, Philippe Roger, Isabelle Dez
  • Journal   :Carbohydrate polymers
  • Year        :   2019

Surface initiated supplemental activator and reducing agent atom transfer radical polymerization (SI-SARA-ATRP) of 4-vinylpyridine on poly (ethylene terephthalate)

  • Authors  : Mohamad Maaz, Tamara Elzein, Alice Bejjani, Nadine Barroca-Aubry, Bénédicte Lepoittevin, Diana Dragoe, Sandra Mazerat, Bilal Nsouli, Philippe Roger
  • Journal   :Journal of colloid and interface science
  • Year        : 2017